BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10385510)

  • 1. Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with low-molecular-weight heparin and with a direct thrombin inhibitor.
    Cella G; Girolami A; Sasahara AA
    Circulation; 1999 Jun; 99(25):3323. PubMed ID: 10385510
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
    Lunven C; Gauffeny C; Lecoffre C; O'Brien DP; Roome NO; Berry CN
    Thromb Haemost; 1996 Jan; 75(1):154-60. PubMed ID: 8713795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
    Xiao Z; Théroux P
    Circulation; 1998 Jan; 97(3):251-6. PubMed ID: 9462526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
    Basic-Micic M; Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions in antithrombotic therapy: emphasis on venous thromboembolism.
    Axelrod DA; Wakefield TW
    J Am Coll Surg; 2001 May; 192(5):641-51. PubMed ID: 11333101
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
    Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different anticoagulants and platelet reactivity in cardiac surgical patients.
    John LC; Rees GM; Kovacs IB
    Ann Thorac Surg; 1993 Oct; 56(4):899-902. PubMed ID: 8215666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):97-103. PubMed ID: 17287624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct thrombin inhibitors: pharmacology and clinical relevance.
    Kam PC; Kaur N; Thong CL
    Anaesthesia; 2005 Jun; 60(6):565-74. PubMed ID: 15918828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential advantages of direct-acting thrombin inhibitors.
    Philippides GJ; Loscalzo J
    Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.
    De Candia E; De Cristofaro R; Landolfi R
    Circulation; 1999 Jun; 99(25):3308-14. PubMed ID: 10385507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin.
    Coughlin MA; Bartlett RH
    ASAIO J; 2015; 61(6):652-5. PubMed ID: 26309096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban.
    Kawai H; Yamamoto T; Hara H; Tamao Y
    Thromb Res; 1994 May; 74(3):185-91. PubMed ID: 8042187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unstable angina pectoris: coagulation disorder and its therapy].
    Meyer BJ
    Praxis (Bern 1994); 1995 Feb; 84(8):232-8. PubMed ID: 7886362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
    Nawarskas JJ; Spinler SA
    Am J Health Syst Pharm; 1996 Apr; 53(8):945. PubMed ID: 8728386
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
    Callas DD; Fareed J
    Thromb Res; 1995 Jun; 78(5):457-60. PubMed ID: 7544924
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action.
    Nylander S; Mattsson C
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):159-67. PubMed ID: 12632026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neointimal proliferation after coronary angioplasty by low-molecular-weight heparin (clivarine) and polyethyleneglycol-hirudin.
    Buchwald AB; Hammerschmidt S; Stevens J; Göring J; Nebendahl K; Unterberg C
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):481-7. PubMed ID: 8891870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.